Occasional constipation (BM generally in 1–3 days)
Adults & children ≥17 yr
17 g (1 capful) in 4–8 oz beverage QD
17 g QD; ≤7 days
Occasional constipation
Children ≤16 yr
Ask a doctor
Undefined
Renal Undefined
Hepatic Undefined
Instructions
Fill cap to top of white section (17 g)
Stir and fully dissolve in 4–8 oz of any beverage (cold, hot or room temp); do not drink if clumps remain
Do not combine with starch-based thickeners (dysphagia)
Available strengths
powder 17 g/dose
Contraindications
Kidney disease, except under a doctor's advice and supervision
Cautions
Ask a doctor first: nausea, vomiting or abdominal pain
Ask a doctor first: sudden change in bowel habits lasting >2 weeks
Ask a doctor first: irritable bowel syndrome
Ask a doctor or pharmacist first if taking a prescription drug
Stop use: rectal bleeding, or worsening nausea, bloating, cramping or abdominal pain
Stop use: diarrhea
Stop use: need for a laxative >1 week
Adverse reactions
Loose, watery, more frequent stools
Pregnancy If pregnant or breast-feeding, ask a health professional before use.
Lactation If pregnant or breast-feeding, ask a health professional before use.
Cost
PEG 3350 (MIRALAX)
Strength
#/mo
generic $/unit
CostPlus
17 g/dose
powder
per unit
not offered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. PEG 3350 is dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.